Citadel Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.2M Sell
237,600
-8,900
-4% -$2.64M 0.01% 1084
2025
Q4
$67.3M Buy
246,500
+102,500
+71% +$27.9M 0.01% 1153
2025
Q3
$38.9M Sell
144,000
-82,500
-36% -$22.4M 0.01% 1630
2025
Q2
$62.4M Buy
226,500
+131,800
+139% +$35.8M 0.01% 1070
2025
Q1
$25.1M Sell
94,700
-35,400
-27% -$8.73M ﹤0.01% 1781
2024
Q4
$30.2M Sell
130,100
-33,700
-21% -$7.75M 0.01% 1734
2024
Q3
$36.1M Sell
163,800
-30,400
-16% -$6.29M 0.01% 1512
2024
Q2
$38.2M Buy
194,200
+3,900
+2% +$806K 0.01% 1371
2024
Q1
$41M Sell
190,300
-134,100
-41% -$28.2M 0.01% 1386
2023
Q4
$68.3M Buy
324,400
+3,800
+1% +$811K 0.01% 947
2023
Q3
$64.2M Buy
320,600
+125,600
+64% +$25M 0.01% 895
2023
Q2
$36.1M Sell
195,000
-144,900
-43% -$26.8M 0.01% 1317
2023
Q1
$65.1M Sell
339,900
-95,200
-22% -$17.2M 0.01% 883
2022
Q4
$73.2M Buy
435,100
+27,900
+7% +$4.85M 0.02% 836
2022
Q3
$72.1M Buy
407,200
+68,800
+20% +$13.6M 0.02% 798
2022
Q2
$69.3M Buy
338,400
+55,900
+20% +$11.8M 0.02% 796
2022
Q1
$67.2M Sell
282,500
-9,400
-3% -$2.21M 0.01% 896
2021
Q4
$66.7M Buy
291,900
+2,500
+0.9% +$550K 0.01% 948
2021
Q3
$56M Buy
289,400
+29,600
+11% +$6M 0.01% 1044
2021
Q2
$55.3M Buy
259,800
+3,200
+1% +$676K 0.01% 1049
2021
Q1
$52.4M Sell
256,600
-25,000
-9% -$4.92M 0.01% 1007
2020
Q4
$51.3M Sell
281,600
-13,600
-5% -$2.31M 0.01% 934
2020
Q3
$49.4M Buy
295,200
+19,400
+7% +$3.27M 0.01% 870
2020
Q2
$44.8M Sell
275,800
-2,500
-0.9% -$448K 0.02% 870
2020
Q1
$48.1M Sell
278,300
-46,200
-14% -$9.2M 0.02% 663
2019
Q4
$65.1M Sell
324,500
-91,300
-22% -$18.7M 0.03% 620
2019
Q3
$87.9M Buy
415,800
+172,200
+71% +$36M 0.04% 460
2019
Q2
$47.3M Buy
243,600
+73,600
+43% +$13.6M 0.02% 758
2019
Q1
$28M Sell
170,000
-123,700
-42% -$21.9M 0.01% 1072
2018
Q4
$55.3M Buy
293,700
+88,300
+43% +$16.3M 0.03% 568
2018
Q3
$35M Buy
205,400
+25,500
+14% +$4.29M 0.02% 972
2018
Q2
$29.5M Sell
179,900
-17,700
-9% -$2.89M 0.01% 1007
2018
Q1
$32M Sell
197,600
-50,900
-20% -$8.1M 0.02% 813
2017
Q4
$36.3M Buy
248,500
+164,400
+195% +$23.4M 0.02% 788
2017
Q3
$11.4M Buy
84,100
+16,200
+24% +$2.05M 0.01% 1490
2017
Q2
$8.5M Sell
67,900
-11,900
-15% -$1.42M 0.01% 1586
2017
Q1
$9.48M Sell
79,800
-111,500
-58% -$13.4M 0.01% 1487
2016
Q4
$22.1M Buy
191,300
+101,100
+112% +$11.3M 0.02% 813
2016
Q3
$9.43M Buy
90,200
+21,900
+32% +$2.29M 0.01% 1413
2016
Q2
$6.65M Sell
68,300
-153,600
-69% -$14.5M 0.01% 1574
2016
Q1
$21.3M Buy
221,900
+27,300
+14% +$2.48M 0.03% 707
2015
Q4
$17.6M Buy
194,600
+73,600
+61% +$6.93M 0.02% 911
2015
Q3
$11.2M Sell
121,000
-54,000
-31% -$5.13M 0.01% 1276
2015
Q2
$16.3M Buy
175,000
+59,800
+52% +$5.58M 0.01% 1139
2015
Q1
$10.9M Sell
115,200
-24,000
-17% -$2.22M 0.01% 1373
2014
Q4
$12.3M Buy
139,200
+14,900
+12% +$1.26M 0.01% 1256
2014
Q3
$9.94M Buy
124,300
+56,700
+84% +$4.27M 0.01% 1367
2014
Q2
$4.8M Buy
67,600
+2,900
+4% +$204K 0.01% 1863
2014
Q1
$4.79M Sell
64,700
-120,300
-65% -$9.07M 0.01% 1825
2013
Q4
$14.5M Buy
185,000
+42,600
+30% +$3.34M 0.02% 982
2013
Q3
$10.5M Sell
142,400
-72,200
-34% -$5.32M 0.02% 1065
2013
Q2
$16.3M Buy
+214,600
New +$14.1M 0.03% 769

Other funds holding CME

Citadel Advisors's CME Position: Q1 2026 in Review

Citadel Advisors reduced its CME Group (CME) stake by 71% in Q1 2026, selling an estimated $274M and leaving 373,956 shares worth $110M. The position accounts for 0.02% of the portfolio, ranked #744.

Citadel Advisors first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $354M in Q4 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Citadel Advisors held 373,956 shares of CME Group worth $110M as of Q1 2026.
  • Citadel Advisors sold 923,691 CME Group shares in Q1 2026, an estimated $274M.
  • CME Group made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #744 holding.
  • Citadel Advisors first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's CME Group position peaked at $354M in Q4 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.